• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Urologix, Inc. (ULGX)

    -Other OTC
    0.07 0.01(14.10%) Dec 18, 3:57PM EST
    Add to Portfolio
    Prev Close:0.08
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.50
    Beta:-0.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.06 - 0.25
    Volume:0
    Avg Vol (3m):32,336
    Market Cap:1.42M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ULGXDown 14.10%1.42M
    LMNS330.27M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from benign prostatic hyperplasia (BPH). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback